coronary artery disease
Conditions
Interventions
300mg loading dose of clopidogrel :NA
Sponsors
Nanjing First Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Adults, aged 18 - 60 years; no abnormal evidence of routine physical examination, including ECG, functional testing of the liver and kidney as well as blood; no medications within 4 weeks before starting of study; willing to sign the written informed consent.
Exclusion criteria
Exclusion criteria: Positive history of allergy to medications, bleeding, platelet dysfunction, peptic ulcer, gastrointestinal disorder, and severe liver and renal failure; medications within 4 weeks before enrollment of clinical study; poor adherence to medications and collaboration; women who are pregnant, breast milk-feeding, and taking oral contraceptives; testing positive for HIV, hepatitis B and C; subjects who participated in drug clinical trials within 3 months before study enrollment; other reasons that are considered not to be appropriate to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| inhibition of platelet aggregation; | — |
Countries
China
Contacts
Public ContactHong-Guang Xie
Nanjing First Hospital
Outcome results
None listed